Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • France
    • +34 96 390 53 10 Request Information
    • +34 96 390 53 10 Request Information
    FranceFrance
    • France
      • Part of brands: |
        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        Cardiology 1

        Cardiology

        Cardiomyopathy is a group of conditions that make it difficult for the heart to pump blood to the rest of the body due to weakness in the heart muscles.
        Cardiomyopathy
        Channelopathy
        Reporting
        Sample
        Methodology
        Limitations

        Cardiomyopathy gene panel Overview

        • Overview
        • Indication
        • Application
        • Cardiomyopathy is a group of conditions that make it difficult for the heart to pump blood to the rest of the body due to weakness in the heart muscles.
        • These diseases affect individuals of all ages and can lead to heart failure and sudden cardiac death. If there is a family history of cardiomyopathy in the family then it is strongly recommended to get genetic testing in order to be aware of the familial risk, personal risk and treatment options.
        • Most types of cardiomyopathy are inherited in a dominant manner, which means that one copy with a gene change is enough for the disease to present in an individual.
        • The symptoms of cardiomyopathy are variable, and these diseases can present in different ways.
        • The most common type of inherited cardiomyopathy is hypertrophic cardiomyopathy

        Some symptoms may include:

        • Shortness of breath
        • Fatigue
        • Arrythmia (abnormal heart rhythm)
        • Dizziness
        • Chest pain

        Associated Diseases:

        • Cardiomyopathy
        • Hypertrophic cardiomyopathy
        • Dilated cardiomyopathy
        • Arrhythmogenic right ventricular cardiomyopathy
        • Left ventricular noncompaction cardiomyopathy

        Channelopathy gene panel

        • Overview
        • Indication
        • Application
        • Cardiac channelopathies are a group of inherited conditions that are associated with problems in the cardiac ion channel function.
        • These problems cause an increased susceptibility to abnormal heart rhythm (dysrhythmia) and sudden death. This occurs due to the malfunction or change in the electrical function of the channels of the heart.

        Some individuals may never show symptoms. Some symptoms may include:

        • Sudden cardiac death in the family
        • Ventricular tachycardia
        • Ventricular fibrillation
        • Family history
        • Abnormal scans

        Associated Diseases

        • Long QT syndrome
        • Brugada syndrome
        • short OT syndrome
        • J-wave syndrome
        • Catecholaminergic polymorphic ventricular tachycaria (CPVT)

        Sample Requirements

        • For genetic testing through next generation sequencing, the following sample types are accepted. A thorough labelling of the tube with unique identifying information is suggested, incorrect labelling can lead to rejection of the sample.
        • The minimum required information to identify and accept a sample is – Patient’s full name, Date of birth, Gender and Medical Record Number.
        • Maternal blood sample must be sent with all products of conception, CVS and Amnio samples.
        • Precedence will be given to all prenatal samples.

        The ‘informed consent’ form and the ‘test requisition from’ (included within the provided kit) must be properly filled-in and signed by the patient and sent with the samples inside the shipping box or by e-mail to the laboratory. Igenomix will send you all the documents needed for the pick-up and transportation of the appropriate kit to our laboratory

        Cardiology Panel Methodology

        Cardiology panel Limitations

        • The probes used for this test are designed to detect known genes in the curated panel. Therefore, this test is unable to detect genes not defined by the NCBI reference genome GRCh37 or non-human genome sequences including viral sequences or non-nuclear DNA that are designated in the specific panel.

        • In addition, due to the limitations of NGS technologies, the following variants cannot be readily detected: large deletions/duplications greater than 40 base pairs, copy number variations, homopolymer stretches, variants in pseudogene regions, gene fusions, balanced translocations, inversions, ploidy changes, uniparental disomy, and repeat expansion regions.

        • Furthermore, variants present outside the exons (non-coding region) could be missed; these variants can affect gene activity and protein production which may lead to genetic disorders. This technique does not cover the entire exome, (the % of bases with coverage above 20x is approximately 97%). It may not be possible to resolve certain details about variants such as mosaicism, phasing, or mapping ambiguity.

        • Analytical limitations may also occur due to the provided clinician information. Accurate and thorough clinical information of the patient(s) and family members is required as incomplete information may lead to false positive or negative results

        • This list of indications and symptoms is not necessarily a comprehensive list and only covers common symptoms associated with disease, signs and symptoms should be discussed with your physician. If you feel like you are affected by one or more of these syndromes visit a doctor immediately. The information presented in this site is not meant to diagnose any medical or genetic condition rather give an overview of the panels presented and offer guidance as to which panel is most appropriate. The associated diseases listed are not necessarily a comprehensive list – more diseases may be added to this list as new information about the disease and the genes associated with these diseases and panels arises

        Fertilité

        Fertilité
        Éviter les maladies génétiques

        Test prénatal non-invasif

        Pour voir le certificat d'accréditation, l'annexe technique associée et la liste des tests accrédités, cliquez sur ce lien.

        Nos services

        Nos services
        Patients
        D'envoyer les échantillons
        Manuel d'utilisateur

        À propos d’Igenomix

        À propos d’Igenomix
        Igenomix dans le monde
        Quality
        Work with us

        SUIVRE IGENOMIX

          + 96 390 53 10
        Écrivez-nous
        • Argentina
        • Brazil
        • Canada
        • Chile
        • Colombia
        • Europe
        • France
        • Germany
        • India
        • Italy
        • Japan
        • Korea
        • Mexico
        • Perú
        • Russia
        • Spain
        • Taiwan
        • The Middle East
        • Turkey
        • United Kingdom
        • United States
        • Vietnam
        France

        [2021] © Igenomix Politique de confidentialité Politique de qualité Note juridique Politique de cookiesActualités et presse 

        Demander des informations


        • reCAPTCHA demo: Simple page

        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        • France
        • +34 96 390 53 10 Request Information

        We are using cookies to give you the best experience on our website.

        You can find out more about which cookies we are using or switch them off in settings.

        France
        Powered by  GDPR Cookie Compliance
        Privacy Overview

        This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

        Strictly Necessary Cookies

        Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

        If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.